Zürcher Nachrichten - Covid-flu joint booster jab possible late 2023: Moderna

EUR -
AED 3.818175
AFN 72.797719
ALL 98.449296
AMD 411.004828
ANG 1.872955
AOA 948.054394
ARS 1066.311715
AUD 1.668113
AWG 1.87116
AZN 1.768965
BAM 1.954396
BBD 2.098393
BDT 124.19081
BGN 1.955581
BHD 0.392145
BIF 3072.59335
BMD 1.039533
BND 1.410387
BOB 7.196831
BRL 6.437413
BSD 1.039254
BTN 88.509435
BWP 14.374677
BYN 3.400558
BYR 20374.855355
BZD 2.090099
CAD 1.497624
CDF 2983.460647
CHF 0.935829
CLF 0.037222
CLP 1027.163148
CNY 7.585372
CNH 7.588908
COP 4586.421522
CRC 527.721006
CUC 1.039533
CUP 27.547636
CVE 110.185868
CZK 25.132789
DJF 185.06709
DKK 7.460721
DOP 63.054716
DZD 140.566631
EGP 52.908195
ERN 15.593002
ETB 132.294989
FJD 2.411977
FKP 0.823292
GBP 0.829486
GEL 2.920682
GGP 0.823292
GHS 15.277028
GIP 0.823292
GMD 74.846661
GNF 8978.551858
GTQ 8.007249
GYD 217.423852
HKD 8.074363
HNL 26.398042
HRK 7.456476
HTG 135.892406
HUF 411.386519
IDR 16854.007582
ILS 3.816247
IMP 0.823292
INR 88.537577
IQD 1361.422265
IRR 43751.368531
ISK 145.098247
JEP 0.823292
JMD 162.233488
JOD 0.737345
JPY 163.308108
KES 134.359917
KGS 90.43918
KHR 4168.006655
KMF 484.552483
KPW 935.579512
KRW 1516.736442
KWD 0.320353
KYD 0.866078
KZT 542.14065
LAK 22741.667577
LBP 93065.16323
LKR 307.719005
LRD 189.144162
LSL 19.151746
LTL 3.069472
LVL 0.628803
LYD 5.103335
MAD 10.455991
MDL 19.13226
MGA 4899.481331
MKD 61.484688
MMK 3376.364052
MNT 3532.334482
MOP 8.317127
MRU 41.38328
MUR 48.930718
MVR 16.006255
MWK 1802.105779
MXN 20.946609
MYR 4.664402
MZN 66.430063
NAD 19.151746
NGN 1609.062836
NIO 38.242535
NOK 11.851383
NPR 141.615296
NZD 1.844195
OMR 0.400229
PAB 1.039254
PEN 3.876416
PGK 4.215972
PHP 60.790857
PKR 289.562045
PLN 4.272583
PYG 8113.173348
QAR 3.788779
RON 4.974478
RSD 116.96726
RUB 103.956844
RWF 1439.366288
SAR 3.902853
SBD 8.714986
SCR 14.844265
SDG 625.277692
SEK 11.524705
SGD 1.413157
SHP 0.823292
SLE 23.699822
SLL 21798.499544
SOS 593.973425
SRD 36.51156
STD 21516.243325
SVC 9.093469
SYP 2611.859198
SZL 19.14625
THB 35.502128
TJS 11.353846
TMT 3.648762
TND 3.309823
TOP 2.434695
TRY 36.647089
TTD 7.05893
TWD 33.975901
TZS 2515.671135
UAH 43.68063
UGX 3819.257117
USD 1.039533
UYU 46.496607
UZS 13408.370487
VES 53.614006
VND 26445.730624
VUV 123.415492
WST 2.87201
XAF 655.486248
XAG 0.035243
XAU 0.000398
XCD 2.809391
XDR 0.796728
XOF 655.486248
XPF 119.331742
YER 260.273179
ZAR 19.359023
ZMK 9357.102525
ZMW 28.761344
ZWL 334.729342
  • RIO

    -0.0800

    59.15

    -0.14%

  • BTI

    -0.0140

    36.206

    -0.04%

  • BCE

    0.1050

    22.945

    +0.46%

  • SCS

    -0.0250

    11.625

    -0.22%

  • CMSC

    -0.1522

    23.7499

    -0.64%

  • NGG

    -0.2730

    58.747

    -0.46%

  • AZN

    -0.3600

    66.27

    -0.54%

  • GSK

    -0.0150

    34.045

    -0.04%

  • JRI

    0.0310

    12.131

    +0.26%

  • BCC

    0.2100

    122.45

    +0.17%

  • RBGPF

    -0.7000

    59.8

    -1.17%

  • RYCEF

    -0.0200

    7.25

    -0.28%

  • BP

    0.1150

    28.865

    +0.4%

  • VOD

    0.0920

    8.462

    +1.09%

  • CMSD

    -0.2700

    23.28

    -1.16%

  • RELX

    0.1650

    45.755

    +0.36%

Covid-flu joint booster jab possible late 2023: Moderna
Covid-flu joint booster jab possible late 2023: Moderna

Covid-flu joint booster jab possible late 2023: Moderna

Moderna aims to roll out a combined Covid-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm said Monday, hoping a joint jab would encourage people to get an annual shot.

Text size:

The single vaccine for Covid-19, influenza and respiratory syncytial virus -- a common virus that causes the cold, but can be more serious for infants and elderly people -- could appear on the market before 2024.

"Best-case scenario will be the fall of '23," Moderna chief executive Stephane Bancel told a virtual World Economic Forum roundtable session.

"I don't think it would happen in every country, but we believe it's possible to happen in some countries next year.

"Our goal is to be able to have a single annual booster so that we don't have compliance issues where people don't want to get two to three shots a winter, but to get one dose."

- Trials in progress -

Bancel said the RSV programme was in Phase III trials -- the final stage of human testing -- while the flu programme should be entering Phase III in the second quarter of this year.

Moderna's experimental flu shot, targeting four major strains, is based on the same mRNA method used in its Covid-19 jabs.

The technology provokes an immune response by delivering genetic molecules containing the code for key parts of a pathogen into human cells.

While Moderna's Covid-19 vaccine was based on the original strain of the virus, it was working on finishing an Omicron-specific jab within weeks, ahead of trials, said Bancel.

"We're hoping in the March timeframe we should be able to have data to share with regulators to figure out the next step forward."

- Hunt for 'holy grail' -

Beyond a vaccine specific to Omicron -- which is rapidly becoming the world's dominant strain -- laboratories are also pursuing a vaccine that works against all current and future Covid-19 mutations.

"There's some private sector partners that are pursuing it," said Richard Hatchett, chief executive of the Coalition for Epidemic Preparedness Innovations, which funds vaccine research and development.

"That would be the holy grail because we really don't want to be in position where we're chasing the new variants that are going to come.

"We don't want to be in a position where we're having to vaccinate everybody in the world every three or six months, or even annually, ideally."

Top US pandemic advisor Anthony Fauci added: "We really don't want to get into the whack-a-mole approach towards every new variant... because you'd be chasing it forever."

Bancel meanwhile said that Moderna had shipped 807 million doses of Covid-19 vaccine in 2021, of which a quarter went to middle- and low-income countries.

Thanks to extra capacity coming on stream before the end of March, the company hopes to be able to make two to three billion doses this year.

T.L.Marti--NZN